In this study, we demonstrated that O‐GlcNAcylation of DDX5 is involved in colorectal cancer progression by activation of AKT/mTOR signalling pathway, which opens up a new sight for the treatment of colorectal cancer. Here, DDX5 is linked to colorectal cancer.